Sky Chemi-Pharma Private Limited, a active private limited company, was established on 26 August 2014 in Mumbai, Maharashtra, India. Engaging in pharmaceutical retailers & distributors within the support service to organizations sector, it holds CIN: U33119MH2014PTC257599. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Adesh Vijay Saple (Director), Sharad Suresh Agarwal (Director), Adnya Adesh Saple (Director). Past directors included Avadhut Balkrishna Rane. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Ground Floor And Basement,K.K Co-Op Hsg End Of Tejpal Scheme, Vile Parle -(East), Mumbai, Maharashtra, 400057.
U33119MH2014PTC257599
257599
26 August 2014
₹0.10 M
₹0.10 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Sky Chemi-Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Adesh Vijay Saple | Director | 26 Aug 2014 | Current |
| Sharad Suresh Agarwal | Director | 01 Mar 2021 | Current |
| Adnya Adesh Saple | Director | 01 Mar 2021 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 01 Mar 2021 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Sky Chemi-Pharma Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 2294.48% increase. The company also saw a substantial improvement in profitability, with a 861.54% increase in profit. The company's net worth Soared by an impressive increase of 30.36%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2020, Sky Chemi-Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Sky Chemi-Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Sky Chemi-Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sky Chemi-Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Sky Chemi-Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
The activity Sky Chemi-Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was completed.
The activity Sharad Suresh Agarwal was appointed as a Director was appointed as a Director on 01 Mar 2021 & has been associated with this company since 4 years 10 months . was completed.
Progress on Adnya Adesh Saple was appointed as a Director was appointed as a Director on 01 Mar 2021 & has been associated with this company since 4 years 10 months . was documented.
The activity Adesh Vijay Saple was appointed as a Director was appointed as a Director on 26 Aug 2014 & has been associated with this company since 11 years 4 months . was completed.
Sky Chemi-Pharma Private Limited was registered on 26 Aug 2014 with Roc Mumbai & aged 11 years 4 months as per MCA records. was recorded as a recent event.
The CIN of Sky Chemi-Pharma Private Limited is U33119MH2014PTC257599.
Sky Chemi-Pharma Private Limited is headquartered at Ground Floor And Basement,K.K Co-Op Hsg End Of Tejpal Scheme, Vile Parle -(East), Mumbai, Maharashtra, 400057.
Sky Chemi-Pharma Private Limited was incorporated on 26 August 2014.
The current directors of Sky Chemi-Pharma Private Limited are
The primary industry of Sky Chemi-Pharma Private Limited is Support Service To Organizations.
Sky Chemi-Pharma Private Limited is unlisted.
The authorized capital of Sky Chemi-Pharma Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
The compliance status of Sky Chemi-Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX